Table 2.
Population demographics for Indian and ROW patients
| Mean India | Mean ROW | N India | N ROW | |
|---|---|---|---|---|
| Age | 51.1 | 52.0 | 1008 | 12,217 |
| BMI | 25.8 | 26.6 | 991 | 11,815 |
| Years with DM | 12.0 | 13.4 | 936 | 8261 |
| Age at diagnosis | 38.8 | 40.0 | 911 | 11,826 |
| Years on pills | 10.6 | 8.1 | 587 | 6020 |
| Years on insulin | 5.5 | 9.0 | 837 | 7405 |
| TDDa regular | 29.3 | 26.6 | 208 | 1214 |
| TDD rapid analogues | 26.2 | 32.1 | 144 | 3323 |
| TDD NPH | 16.5 | 32.6 | 73 | 1061 |
| TDD basal analogues | 23.0 | 27.9 | 285 | 4424 |
| TDD premix | 34.9 | 46.5 | 545 | 1251 |
| Overall TDD | 36.9 | 50.2 | 982 | 6774 |
| HbA1c | 8.6 | 8.5 | 896 | 6767 |
ROW (rest of world) constitutes the mean values of the 41 other ITQ participating countries combined (excluding India)
aTTD (total daily dose) of insulin is the combined total of all insulin used in 1 day in IU (international units)